OSWEGO, N.Y. — Oswego Health says it has purchased the cobas 5800 System, which it describes as a fully automated molecular laboratory instrument.
It offers a flexible PCR testing product to enable “accurate and reliable” diagnosis of infectious diseases, including chlamydia, gonorrhea, COVID-19, and HPV testing, Oswego Health said in its Wednesday announcement.
The system is built to offer a fully automated workflow and offers an expanded onboard capacity, allowing labs to test multiple assays simultaneously. It takes about 2.5 hours to produce the first 24 results. With 24 more results ready every 60 minutes thereafter, cobas 5800 has the capability of delivering up to 144 results in 8 hours.
(Sponsored)
Why Now Is the Time To Start Planning for Your Company’s Business Succession
You’ve built a great business, and you love what you do. Retirement is a long way off, so why worry about how you’ll transition the ownership of your company down
Ask the Expert: Investing in the Future with Registered Apprenticeship
In today’s competitive job market, finding and retaining top talent can be incredibly challenging. For companies, Registered Apprenticeship is an investment not only in its employees but in its future.
Oswego Health says it’s the fourth health-care system in the country to purchase the cobas 5800 System.
